Markets
5.5
GSK to cut 1,217 jobs in Wallonia, pivots to oncology from vaccines
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateLe MondeBE · GB
HealthReportedMedium
5.2
AstraZeneca to Present Survival Data from Four Phase 3 Trials at ESMO 2026
AstraZeneca will present overall survival data from four Phase 3 studies (Sone-Ve, Imfinzi, Tagrisso, Orpathys) at the ESMO 2026 Presidential Symposia. The data could influence treatment paradigms in oncology and impact AstraZeneca's competitive position, but results are not yet disclosed.
Score Breakdown
Mosaic Score5.2
Model confidence0.9
Significance0.5
Source credibility0.3
Intelligence Tags
Related signals
8 foundHealth
1.9
Caliway Biopharmaceuticals' novel injectable drug shows promise for millions
Published 2 d ago1 sourceEvidence: Reported
Poslovni DnevnikLow-rated source
Health
6.2
Roche reviews Germany investments over healthcare cost cuts; Gilead bowel drug advances
Published 2 d ago4 sourcesEvidence: Reported
SeverityModerateAssessedDeveloping storySTAT NewsLow-rated sourceDE · US
Geopolitics
5.8
Greece targets major role in European pharma production, research
Published 2 d ago3 sourcesEvidence: Reported
SeverityModerateCapital.grLow-rated sourceGR
Health
5.2
Lilly criticizes Belgium's refusal to reimburse obesity drug Mounjaro
Published 8 h ago1 sourceEvidence: Reported
SeverityModerateLe SoirLow-rated sourceBE
Health
5.1
Slovak President Signs Healthcare Reform to Tighten Drug Supply Chain
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateAktualityLow-rated sourceSK
Health
5.1
GSK wins FDA approval for hepatitis B drug, expands functional cure rates
Published 3 h ago1 sourceEvidence: Reported
SeverityModerateSTAT NewsLow-rated sourceUS
Health
5.0
US new drug launch prices dip slightly but remain high; median net price up 35% since 2022
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateSTAT NewsLow-rated sourceUS